ライフサイエンスコーパス: mesenteric ischemia

1 fter heart operation (P = 0.03 compared with mesenteric ischemia).

2 atient eventually died because of subsequent mesenteric ischemia.

3 atients with intestinal failure secondary to mesenteric ischemia.

4 s play an important role in the diagnosis of mesenteric ischemia.

5 ies that report on current outcome for acute mesenteric ischemia.

6 lood flow in this model of endotoxin-induced mesenteric ischemia.

7 is a promising test for diagnosis of chronic mesenteric ischemia.

8 case vignette of a frail patient with acute mesenteric ischemia.

9 se patients may predict the onset of chronic mesenteric ischemia.

10 e asymptomatic and 3 had symptoms of chronic mesenteric ischemia.

11 ment of operative risk (standard deviations: mesenteric ischemia 20.2% vs 23.2%, P = 0.01; gastrointe

12 patients), cardiac ischemia (6.6% vs 5.6%), mesenteric ischemia (3.2% vs 2.6%), and peripheral ische

13 compared with surgeons in the control group [mesenteric ischemia: 43.7% vs 64.6%, P < 0.001 (RCV = 25

14 investigate the prognostic factors of acute mesenteric ischemia (AMI) in ICU patients.

15 hospital mortality of in-patients with acute mesenteric ischemia (AMI) over the past decade and effec

16 Acute mesenteric ischemia (AMI) remains a complex and difficul

17 ons (transaminitis, ileus, Ogilvie syndrome, mesenteric ischemia) among critically ill patients with

18 osses were sustained by the hospital for the mesenteric ischemia and infected aortic graft groups amo

19 tural and functional changes associated with mesenteric ischemia and reperfusion in rats.

20 al damage to the intestinal mucosa caused by mesenteric ischemia and reperfusion in rats.

21 xygen species-mediated tissue injury, namely mesenteric ischemia and reperfusion in rats.

22 IL-1alpha treatment attenuates mesenteric ischemia and reperfusion injury induced by th

23 tients with ongoing coronary, peripheral, or mesenteric ischemia, and should be used with caution in

24 laparotomy confirmed extensive nonocclusive mesenteric ischemia, and the patient rapidly died of mul

25 and/or preemptively diagnosis postcardiotomy mesenteric ischemia are necessary to decrease its associ

26 e initial workup in cases of suspected acute mesenteric ischemia because it can rule out other causes

27 to detect and treat thromboses can result in mesenteric ischemia, chronic cavernous transformation, a

28 at 5 g once daily in a patient with chronic mesenteric ischemia (CMI) for chronic loose, frequent, a

29 consecutive series of patients with chronic mesenteric ischemia (CMI) who were treated with percutan

30 patients (17%) underwent bowel resection for mesenteric ischemia, compared with 3% in pre-COVID SVT (

31 clinician to identify patients in whom acute mesenteric ischemia develops.

32 in vivo, can be used to diagnose and monitor mesenteric ischemia due to hemorrhagic shock in a canine

33 nts undergoing revascularization for chronic mesenteric ischemia, elective thoracoabdominal aortic an

34 nesthesia, rats were subjected to 60 mins of mesenteric ischemia followed by 60 mins of reperfusion.

35 od flow by 60% in this model of nonocclusive mesenteric ischemia (from 168 +/- 41 to 269 +/- 76 mL/mi

36 767) with four detailed clinical vignettes (mesenteric ischemia, gastrointestinal bleed, bowel obstr

37 Mesenteric ischemia, infection, and inflammatory bowel d

38 Acute mesenteric ischemia is an abdominal emergency because re

39 Acute mesenteric ischemia is associated with high morbidity an

40 y be an effective treatment for nonocclusive mesenteric ischemia, it has also been advocated to incre

41 ficits, altered mental status, myocardial or mesenteric ischemia, kidney failure, hypotension, cardia

42 ssess intestinal viability in a laparoscopic mesenteric ischemia model.

43 raluminally into the ileum before 45 minutes mesenteric ischemia or before reperfusion in non-CH4 pro

44 cm (OR, 6.04; 95% CI, 2.87-12.73; P<0.001), mesenteric ischemia (OR, 9.03; 95% CI, 3.49-23.38; P<0.0

45 on, arterial thromboembolism, renal failure, mesenteric ischemia, or hepatic insufficiency occurred.

46 , viral colitis, inflammatory enterocolitis, mesenteric ischemia, radiation-induced gastrointestinal

47 ue damage, we also studied its expression in mesenteric ischemia-reperfusion (I/R) injury.

48 tial of phosphatidylserine in a rat model of mesenteric ischemia-reperfusion and to explore its under

49 Mesenteric ischemia-reperfusion injury was induced in ma

50 Acute mesenteric ischemia-reperfusion is a life-threatening co

51 sm repair, with its requisite intraoperative mesenteric ischemia-reperfusion, often results in the de

52 2-deficient (Cr2(-/-)) mice are resistant to mesenteric ischemia/reperfusion (I/R) injury because the

53 tural Abs have been implicated in initiating mesenteric ischemia/reperfusion (I/R)-induced tissue inj

54 lthough not as common, the mortality rate of mesenteric ischemia/reperfusion (IR) remains >70%.

55 nhibited repair of damaged mucosa induced by mesenteric ischemia/reperfusion in the small intestine a

56 trates that the mechanism of U74389F against mesenteric ischemia/reperfusion includes a delay and red

57 mplement activation prevents and/or reverses mesenteric ischemia/reperfusion-induced injury in mice.

58 f the gut barrier function after exposure to mesenteric ischemia/reperfusion.

59 e to the intestinal mucosa in a rat model of mesenteric ischemia/reperfusion.

60 Background Acute arterial mesenteric ischemia requires emergency treatment and is

61 se and six patients with symptomatic chronic mesenteric ischemia, the same measurements were obtained

62 small bowel enteroscopy; early diagnosis of mesenteric ischemia; the use of polymerase chain reactio

63 n after four cycles (n = 6), or nonocclusive mesenteric ischemia was induced by pericardial tamponade

64 Nonocclusive acute mesenteric ischemia was induced by pericardial tamponade

65 The incidence of nonocclusive mesenteric ischemia was particularly high.

66 The diagnosis of acute mesenteric ischemia was proposed based on evidence of po

67 Mesenteric ischemia was the primary cause of CIF (32%).

68 he most frequent serious GI complication was mesenteric ischemia, which developed in 31 (67%) patient

69 hic GI complication after cardiac surgery is mesenteric ischemia, which is frequently fatal.

70 Of the 9 patients with mesenteric ischemia who were not explored, 7 (78%) died

71 IRF survival in patients with acute arterial mesenteric ischemia whose first-line treatment was endov

72 als and Methods Patients with acute arterial mesenteric ischemia whose first-line treatment was endov

73 IRF survival in patients with acute arterial mesenteric ischemia whose first-line treatment was endov